Pennsylvania’s Response to the COVID-19 Pandemic
Pennsylvania has a rich history of innovative life-saving treatments and cures for the world’s greatest health problems and when faced with a global pandemic, our companies step up to the challenge.
Join us for an educational briefing to learn about the measures the Pennsylvania life sciences industry is taking to combat COVID-19. We will cover vaccines, therapies and diagnostics that are in development to combat this novel coronavirus.
Event Details
Date: April 24, 2020
Time: 10:00 a.m.- 10:45 a.m.
*To receive the dial-in information you must register for the event. LSPA will provide the dial-in information once you are registered.
SPEAKERS
Julie Gerberding, Executive Vice President & Chief Patent Officer, Strategic Communications, Global Public Policy and Population Health, Merck
As the former CDC director, Julie will not only be discussing vaccine development, but also public health preparedness with deep experience in managing public health emergencies.
Bill Mezzanotte, Executive Vice President, Head Research & Development, CSL Behring
Bill will be speaking to CSL Behring’s work on plasma therapy for patients with COVID-19.
Steve Tang, Chief Executive Officer, OraSure Technologies, Inc.
Steve will address OraSure’s efforts to develop a COVID-19 antibody test.
